You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 282 No. 10, September 8, 1999 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Advances in Medical Care: Promise, Problems, and Proper Application

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: In their discussion of pseudodisease caused by growth of medical care, Drs Fisher and Welch1 highlight the largely unexplored area of disagreement in pathologists' diagnoses of early malignancy and malignant precursors. This diagnostic disagreement is a red flag for the identification of pathogenic pathology reports. However, if the associated morbidity is to be prevented, it is important that we understand the pathogenesis of the resulting pseudodisease.

An important cause of neoplastic pseudodisease is the flawed classification system. Confirming the thesis of Fisher and Welch, these flawed systems become increasingly virulent when used to guide the interpretation of biopsies from larger and larger numbers of clinically healthy people, especially when these people will be offered aggressive treatment options for a "positive" biopsy result. Examples of the impact of a flawed classification system are found among the 500,000 to 1 million breast biopsies performed each year in the United . . . [Full Text of this Article]







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.